XML 43 R5.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statement of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Nov. 30, 2019
Nov. 30, 2018
Cash flows from operating activities:    
Net income (loss) $ 178,737 $ 347,115
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Depreciation and amortization 136,643 137,779
Income (Loss) from Equity Method Investments, Net of Dividends or Distributions (30,468) (47,621)
Provision for doubtful accounts 1,775 5,009
Deferred taxes (3,579) 26,555
Other, net 8,341 (3,162)
Changes in operating assets and liabilities, net of acquisitions:    
Receivables 108,495 (182,767)
Inventories (514,580) (416,196)
Accounts payable and accrued expenses 386,021 299,741
Other liabilities (110,684) (261,251)
Net cash provided by (used in) operating activities 160,701 (94,798)
Cash flows from investing activities:    
Acquisition of property, plant and equipment (131,808) (104,750)
Proceeds from disposition of property, plant and equipment 3,015 5,752
Expenditures for major repairs (7,691) (3,441)
Changes in CHS Capital notes receivable, net 15,195 (126,865)
Financing extended to customers (915) (3,928)
Payments from customer financing 4,209 71,137
Other investing activities, net 3,046 7,319
Net cash provided by (used in) investing activities (114,949) (154,776)
Cash flows from financing activities:    
Proceeds from lines of credit and long-term borrowings 5,414,395 4,429,276
Payments on lines of credit, long-term borrowings and capital lease obligations (5,445,420) (4,317,479)
Preferred stock dividends paid (42,167) (42,167)
Redemptions of equities (5,447) (24,072)
Other financing activities, net 6,757 3,503
Net cash provided by (used in) financing activities (71,882) 49,061
Effect of exchange rate changes on cash and cash equivalents (1,153) (1,535)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (27,283) (202,048)
Cash and cash equivalents and restricted cash at beginning of period 299,675 543,940
Cash and cash equivalents and restricted cash at end of period $ 272,392 $ 341,892